vs
Byrna Technologies Inc.(BYRN)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Byrna Technologies Inc.的2.0倍($69.8M vs $35.2M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 9.5%,领先374.5%),Byrna Technologies Inc.同比增速更快(26.0% vs 21.2%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 45.5%)
Byrna Technologies Inc.是一家专注于非致命个人安全及自卫产品研发、生产与销售的企业,核心产品包括手持式动能发射器、专用非致命投射弹及相关配件,服务个人消费者、执法机构、私营安保公司及教育机构,核心市场覆盖北美并正拓展全球布局。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
BYRN vs RIGL — 直观对比
营收规模更大
RIGL
是对方的2.0倍
$35.2M
营收增速更快
BYRN
高出4.8%
21.2%
净利率更高
RIGL
高出374.5%
9.5%
两年增速更快
RIGL
近两年复合增速
45.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $35.2M | $69.8M |
| 净利润 | $3.4M | $268.1M |
| 毛利率 | 59.8% | 91.5% |
| 营业利润率 | 11.2% | 33.2% |
| 净利率 | 9.5% | 384.0% |
| 营收同比 | 26.0% | 21.2% |
| 净利润同比 | -65.2% | 1769.2% |
| 每股收益(稀释后) | $0.14 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BYRN
RIGL
| Q4 25 | $35.2M | $69.8M | ||
| Q3 25 | $28.2M | $69.5M | ||
| Q2 25 | $28.5M | $101.7M | ||
| Q1 25 | $26.2M | $53.3M | ||
| Q4 24 | $28.0M | $57.6M | ||
| Q3 24 | $20.9M | $55.3M | ||
| Q2 24 | $20.3M | $36.8M | ||
| Q1 24 | $16.7M | $29.5M |
净利润
BYRN
RIGL
| Q4 25 | $3.4M | $268.1M | ||
| Q3 25 | $2.2M | $27.9M | ||
| Q2 25 | $2.4M | $59.6M | ||
| Q1 25 | $1.7M | $11.4M | ||
| Q4 24 | $9.7M | $14.3M | ||
| Q3 24 | $1.0M | $12.4M | ||
| Q2 24 | $2.1M | $-1.0M | ||
| Q1 24 | $17.0K | $-8.2M |
毛利率
BYRN
RIGL
| Q4 25 | 59.8% | 91.5% | ||
| Q3 25 | 60.1% | 93.2% | ||
| Q2 25 | 61.6% | 95.6% | ||
| Q1 25 | 60.8% | 91.7% | ||
| Q4 24 | 62.8% | 89.9% | ||
| Q3 24 | 62.4% | 85.5% | ||
| Q2 24 | 62.0% | 92.4% | ||
| Q1 24 | 57.9% | 93.1% |
营业利润率
BYRN
RIGL
| Q4 25 | 11.2% | 33.2% | ||
| Q3 25 | 10.2% | 40.9% | ||
| Q2 25 | 11.7% | 60.1% | ||
| Q1 25 | 6.5% | 23.9% | ||
| Q4 24 | 14.6% | 28.9% | ||
| Q3 24 | 4.0% | 25.4% | ||
| Q2 24 | 9.4% | 1.2% | ||
| Q1 24 | -1.0% | -23.6% |
净利率
BYRN
RIGL
| Q4 25 | 9.5% | 384.0% | ||
| Q3 25 | 7.9% | 40.2% | ||
| Q2 25 | 8.5% | 58.6% | ||
| Q1 25 | 6.3% | 21.5% | ||
| Q4 24 | 34.6% | 24.9% | ||
| Q3 24 | 4.9% | 22.5% | ||
| Q2 24 | 10.2% | -2.8% | ||
| Q1 24 | 0.1% | -27.9% |
每股收益(稀释后)
BYRN
RIGL
| Q4 25 | $0.14 | $14.11 | ||
| Q3 25 | $0.09 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.07 | $0.63 | ||
| Q4 24 | $0.42 | $0.82 | ||
| Q3 24 | $0.04 | $0.70 | ||
| Q2 24 | $0.09 | $-0.06 | ||
| Q1 24 | $0.00 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $65.8M | $391.5M |
| 总资产 | $84.5M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
BYRN
RIGL
| Q4 25 | $15.5M | $155.0M | ||
| Q3 25 | $9.0M | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | $19.3M | $77.1M | ||
| Q4 24 | $25.7M | $77.3M | ||
| Q3 24 | $20.1M | $61.1M | ||
| Q2 24 | $24.8M | $49.1M | ||
| Q1 24 | $24.2M | $49.5M |
总债务
BYRN
RIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益
BYRN
RIGL
| Q4 25 | $65.8M | $391.5M | ||
| Q3 25 | $63.1M | $117.6M | ||
| Q2 25 | $60.1M | $81.9M | ||
| Q1 25 | $56.8M | $18.6M | ||
| Q4 24 | $54.4M | $3.3M | ||
| Q3 24 | $44.5M | $-14.6M | ||
| Q2 24 | $45.3M | $-29.9M | ||
| Q1 24 | $43.2M | $-31.7M |
总资产
BYRN
RIGL
| Q4 25 | $84.5M | $513.6M | ||
| Q3 25 | $78.6M | $242.5M | ||
| Q2 25 | — | $206.7M | ||
| Q1 25 | $71.0M | $176.0M | ||
| Q4 24 | $71.9M | $164.0M | ||
| Q3 24 | $59.0M | $139.4M | ||
| Q2 24 | $57.5M | $128.4M | ||
| Q1 24 | $52.7M | $126.5M |
负债/权益比
BYRN
RIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $9.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | — |
| 自由现金流率自由现金流/营收 | 23.1% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | 2.95× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-9.2M | — |
8季度趋势,按日历期对齐
经营现金流
BYRN
RIGL
| Q4 25 | $9.9M | $22.0M | ||
| Q3 25 | $-2.3M | $24.0M | ||
| Q2 25 | $-5.5M | $30.5M | ||
| Q1 25 | $-3.8M | $-893.0K | ||
| Q4 24 | $7.3M | $14.5M | ||
| Q3 24 | $-1.4M | $21.7M | ||
| Q2 24 | $1.9M | $302.0K | ||
| Q1 24 | $3.9M | $-5.0M |
自由现金流
BYRN
RIGL
| Q4 25 | $8.1M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-6.4M | — | ||
| Q1 25 | $-6.4M | — | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $3.8M | — |
自由现金流率
BYRN
RIGL
| Q4 25 | 23.1% | — | ||
| Q3 25 | -16.0% | — | ||
| Q2 25 | -22.4% | — | ||
| Q1 25 | -24.5% | — | ||
| Q4 24 | 22.5% | — | ||
| Q3 24 | -10.0% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 22.6% | — |
资本支出强度
BYRN
RIGL
| Q4 25 | 5.1% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 1.0% | — |
现金转化率
BYRN
RIGL
| Q4 25 | 2.95× | 0.08× | ||
| Q3 25 | -1.01× | 0.86× | ||
| Q2 25 | -2.25× | 0.51× | ||
| Q1 25 | -2.27× | -0.08× | ||
| Q4 24 | 0.75× | 1.01× | ||
| Q3 24 | -1.36× | 1.75× | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 231.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BYRN
| E Commerce | $23.0M | 65% |
| Wholesale Dealerdistributors | $10.9M | 31% |
| Other | $1.3M | 4% |
RIGL
暂无分部数据